costimulatory bispecific antibodies, and a pioneering combination of a monoclonal antibody and small interfering RNA (siRNA). “Our presentations at ASH demonstrate the progress we are making toward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback